Sanofi (EPA:SAN) has been assigned a €95.00 ($117.28) price target by equities research analysts at Credit Suisse Group in a research report issued on Thursday. The brokerage presently has a “buy” rating on the stock. Credit Suisse Group’s price target would indicate a potential upside of 44.31% from the company’s previous close.

A number of other brokerages have also commented on SAN. Jefferies Group set a €80.00 ($98.77) price objective on Sanofi and gave the company a “neutral” rating in a report on Tuesday, January 16th. Deutsche Bank set a €93.00 ($114.81) price objective on Sanofi and gave the company a “buy” rating in a report on Tuesday, January 30th. UBS Group set a €82.00 ($101.23) price objective on Sanofi and gave the company a “neutral” rating in a report on Tuesday, January 30th. Goldman Sachs Group set a €82.00 ($101.23) price objective on Sanofi and gave the company a “neutral” rating in a report on Monday, January 29th. Finally, S&P Global set a €78.00 ($96.30) price objective on Sanofi and gave the company a “neutral” rating in a report on Tuesday, January 23rd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the company’s stock. Sanofi currently has an average rating of “Hold” and an average price target of €85.00 ($104.94).

Sanofi (EPA:SAN) opened at €65.83 ($81.27) on Thursday. Sanofi has a 1-year low of €65.30 ($80.62) and a 1-year high of €92.97 ($114.78). The company has a market capitalization of $83,150.00 and a price-to-earnings ratio of 21.80.

ILLEGAL ACTIVITY NOTICE: “Sanofi (SAN) PT Set at €95.00 by Credit Suisse Group” was first reported by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.dailypolitical.com/2018/02/08/sanofi-san-pt-set-at-95-00-by-credit-suisse-group.html.

About Sanofi

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.